|
|
Article: Revolutionary drug brings new hope for adrenal cancer patients.
- Article from:
- Asian News International
- Article date:
- September 23, 2009
CopyrightCOPYRIGHT 2009 Al Bawaba (Middle East) Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Byline: ANI
Washington, September 23 (ANI): Researchers are hopeful that a clinical trial of a new drug will help patients of adrenocortical carcinoma (ACC), a rare but aggressive cancer that hits the adrenal glands.
TGen (Translational Genomics Research Institute) Clinical Research Services (TCRS) at Scottsdale Healthcare made the announcement.
Experts are crossing their fingers, wishing the new compound, OSI-906, developed by OSI Pharmaceuticals Inc. of Melville, N.Y., will put an end to ACC tumor growth minus the toxic side effects of present chemotherapies.
Dr. Michael J. Demeure, a TGen Senior Investigator and a Scottsdale ...